News 3SBio Inc.

Equities

1530

KYG8875G1029

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 08:08:09 13/02/2026 GMT			5-day change	1st Jan Change
23.40 ^HKD	-0.17%		+2.01%	-3.23%

12-02	3SBio Seeks HK$3.12 Billion via Share Sale	MT
12-02	3SBio to place 105.2 million shares	RE

All News

12-02	3SBio Seeks HK$3.12 Billion via Share Sale	MT
12-02	3SBio to place 105.2 million shares	RE
11-21	3SBio Proposes Spinoff, Hong Kong Listing of Unit Mandi	MT
11-20	3SBio proposes spin-off and listing of Mandi Inc. on HKSE	RE
11-19	3SBio Inc. agreed to Spin-Off unknown minority stake in Mandi Inc.	CI
08/09/25	BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in phase II trial	RE
01/09/25	3SBio : 2025 Interim Results Presentation	PU
29/08/25	3SBio Inc. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
29/08/25	3SBio's Profit Jumps 25% in H1	MT
29/08/25	3SBio posts H1 gross margin of 85.3%	RE
29/08/25	Tranche Update on 3SBio Inc.'s Equity Buyback Plan announced on June 25, 2024.	CI
05/08/25	Pfizer raises 2025 profit forecast as cost-cutting program gains traction	RE
24/07/25	3SBio, Pfizer Complete Exclusive License Contract for Cancer Drug	MT
24/07/25	Pfizer Finalizes $1.25 Billion Licensing Agreement for Cancer Drug With 3SBio	MT
24/07/25	Pfizer Inc. Completes Licensing Agreement with 3SBio, Inc	CI
24/07/25	Pfizer completes licensing agreement with 3SBio	RE
25/06/25	3SBio Inc. Announces Changes in Composition of the Nomination Committee, with Effect from 25 June 2025	CI
25/06/25	3SBio Inc. Declares Final Dividend for the Year Ended 31 December 2024, Payable on 15 August 2025	CI
20/05/25	Sector Update: Health Care Stocks Rise in Afternoon Trading	MT
20/05/25	Sector Update: Health Care	MT
20/05/25	US Equity Indexes Decline in Midday Trading	MT
20/05/25	Pfizer Strikes up to $6.05 Billion Licensing Deal for 3SBio's Cancer Drug Candidate	MT
20/05/25	3SBio to Grant Pfizer Exclusive License for Anti-Cancer Injection	MT
20/05/25	Pfizer Signs Licensing Deal With China's 3SBio for Cancer Treatment Candidate	MT
20/05/25	Hong Kong Stocks Rise as China Cuts Interest Rates; CATL Jumps 16% in Debut	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

3SBio stock surges after acquiring licensing rights to cancer drug

March 21, 2025 at 06:49 am